Holen Sie sich die Stockscreener-App
10.23
0.10%
-0.02
Delcath Systems Inc Aktie (DCTH) Neueste Nachrichten
Delcath reports $85.2 million in 2025 revenue, strong cash position By Investing.com - Investing.com Canada
Delcath Systems (DCTH) Exceeds Revenue Expectations in Q4 and Fu - GuruFocus
Delcath Systems announces preliminary fourth quarter and full year 2025 financial results - MarketScreener
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - The AI Journal
ETF Watch: Will Delcath Systems Inc. stock remain a Wall Street favoriteTrade Ideas & Reliable Price Breakout Signals - ulpravda.ru
Will Delcath Systems Inc. stock remain a Wall Street favoriteMarket Volume Summary & Daily Technical Forecast Reports - ulpravda.ru
Shorts Report: Will Delcath Systems Inc stock remain a Wall Street favorite2025 Earnings Impact & Daily Growth Stock Investment Tips - moha.gov.vn
A Look At Delcath Systems (DCTH) Valuation After New Phase 3 FOCUS Subgroup Data On HEPZATO KIT - Sahm
Under the Radar: 3 Microcap Growers Passing a Tough Test - Benzinga
Will Delcath Systems Inc. stock sustain high P E ratios2026 world cup usa national team round of 16 key players high defensive line match prediction expert opinion - ulpravda.ru
Will New HEPZATO KIT Subgroup Data on Tumor Burden and Survival Change Delcath Systems' (DCTH) Narrative - Sahm
(DCTH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Should New HEPZATO Subgroup Data and Delcath’s Targeted Strategy Require Action From DCTH Investors? - Yahoo Finance
Are options traders betting on a big move in Delcath Systems stock? - MSN
Delcath Systems Inc Stock Analysis and ForecastLong-Term Growth Stocks & Fast Growing Investment Plans - earlytimes.in
Hepzato Kit Safe, Effective in Metastatic, Unresectable Uveal Melanoma - Cure Today
Are Options Traders Betting on a Big Move in Delcath Systems Stock? - Yahoo Finance
Delcath Systems publishes results from subgroup analyses of FOCUS study - Yahoo Finance
Delcath’s HEPZATO shows consistent efficacy across patient subgroups By Investing.com - Investing.com Nigeria
Delcath Systems (DCTH) Reveals Key Findings from FOCUS Study Sub - GuruFocus
Delcath’s HEPZATO shows consistent efficacy across patient subgroups - Investing.com
Which metastatic uveal melanoma patients gain most from a liver-directed drug? - Stock Titan
Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma - Yahoo Finance
Simplify Asset Management Inc. Increases Stock Position in Delcath Systems, Inc. $DCTH - MarketBeat
Glenmark Pharmaceuticals Limited (532296) Gets Regulatory ApprovalFibonacci Extensions & Build Wealth With Strategy - bollywoodhelpline.com
Book value per share of Delcath Systems, Inc. – MUN:DV3R - TradingView — Track All Markets
Bearish Setup: Is Delcath Systems Inc stock a smart buy before Fed meetingTrade Entry Summary & Advanced Technical Signal Analysis - moha.gov.vn
Precision Trading with Delcath Systems Inc. (DCTH) Risk Zones - Stock Traders Daily
Delcath Systems, Inc. (NASDAQ:DCTH) is a favorite amongst institutional investors who own 51% - Yahoo Finance
Delcath Systems (STU:DV3R) EV-to-OCF : 19.88 (As of Dec. 21, 2025) - GuruFocus
Why Delcath Systems Inc. (DV3R) stock stays on buy lists2025 Biggest Moves & Entry Point Strategy Guides - bolumsonucanavari.com
Delcath Systems Earnings Notes - Trefis
Delcath Systems authorizes $25 million share repurchase program - MSN
Can Delcath Systems Inc. (DV3R) stock hold up in economic slowdownCEO Change & Risk Controlled Daily Trade Plans - Bölüm Sonu Canavarı
Do Options Traders Know Something About Delcath Systems Stock We Don't? - MSN
Will Delcath Systems Inc. (DV3R) stock sustain bullish trend into 2025Inflation Watch & Long-Term Safe Return Strategies - DonanımHaber
Is Delcath Systems Inc. stock a safe haven assetPortfolio Return Report & Reliable Intraday Trade Plans - Улправда
Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Here’s What Hit Delcath Systems (DCTH) in Q3 - Insider Monkey
How Delcath Systems Inc. (DCTH) Affects Rotational Strategy Timing - Stock Traders Daily
Vivo Capital LLC Decreases Stake in Delcath Systems, Inc. $DCTH - MarketBeat
Delcath Systems, Inc. (DCTH) Misses Q1 Earnings Estimates - sharewise.com
How higher bond yields impact Delcath Systems Inc. (DV3R) stock2025 Key Highlights & High Conviction Investment Ideas - Newser
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH) and Champions Oncology (CSBR) - The Globe and Mail
How Delcath Systems Inc. (DV3R) stock reacts to Fed tighteningPortfolio Risk Summary & Daily Stock Trend Watchlist - Newser
Why Delcath Systems Inc. (DV3R) stock trades below fair valueQuarterly Trade Report & Daily Stock Trend Reports - Newser
Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma - BioSpace
Delcath reports 29-month survival in liver cancer treatment study - Investing.com India
Delcath reports 29-month survival in liver cancer treatment study By Investing.com - Investing.com Nigeria
Delcath Systems (DCTH) Showcases Promising Study Results for Liv - GuruFocus
0.54%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):